Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.390
+0.010 (0.30%)
Feb 3, 2026, 10:24 AM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 91.11 million as of February 3, 2026. Its market cap has increased by 33.01% in one year.
Market Cap
91.11M
Enterprise Value
143.78M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.39
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 91.11M, a decrease of -86.37%. That is a compound annual growth rate of -33.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 91.11M | 3.05% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 1.72B |
| ArcticZymes Technologies ASA | 1.13B |
| Nykode Therapeutics AS | 1.04B |
| Lytix Biopharma AS | 711.84M |
| Zelluna ASA | 393.99M |
| Circio Holding ASA | 165.74M |
| SoftOx Solutions AS | 144.38M |
| EXACT Therapeutics AS | 117.67M |